By Christine Chen (Reuters) -Australian biopharmaceutical company CSL said on Tuesday that falling immunisation rates in the ...

Motilal Oswal expects a CAGR of 12%/11%/17% in revenue/EBITDA/PAT over CY24-26 and largely maintained CY25/CY26 earnings ...

Analysts have put buy ratings on these shares. Let's see what they are recommending. The post 3 top Australian shares to buy ...

Matthew Parden, CEO at Marygold & Co, shared his insights: "The biggest unknown is the exact impact of last year’s budget on ...

Commonwealth Bank of Australia's strong asset quality is expected to help the lender deliver marginal cash earnings growth in the first half, though analysts believe its lofty valuation seems ...

Shares of cybersecurity firm Palo Alto Networks (PANW) finished up in today’s trading as investors await its Q2 earnings ...

Shares of financial services platform Robinhood (HOOD) are up in today’s trading as investors await its Q4 earnings results ...

Through Friday, with the latest quarterly results in from more than three-fifths of the S&P 500, 77% have turned in earnings per share higher than analysts expected, according to FactSet.

In recent years, investors have increasingly shifted away from UK equities, favoring global stocks, particularly high-growth ...

Have a consensus Buy rating: All of the stocks must have an average broker recommendation of 2.5 or less within S&P Global ...

AMD's Q4 earnings report shows strong revenue growth but concerns about stagnant margins and limited growth. Click here to ...

In the fast-paced world of investing, staying ahead requires good ideas and timely decisions. This article highlights five stocks worth watching each week for their robust performance, market trends, ...